Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1245, 2009-01, pp. : 16-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Efalizumab withdrawal: Erythroderma: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. :
Efalizumab: Candidiasis: case report
Reactions Weekly, Vol. 1, Iss. 1226, 2008-01 ,pp. :
Efalizumab: Pancytopenia: case report
Reactions Weekly, Vol. 1, Iss. 1211, 2008-01 ,pp. :
Efalizumab: Cryptococcal meningitis: case report
Reactions Weekly, Vol. 1, Iss. 1231, 2008-01 ,pp. :
Efalizumab: Seborrhoeic keratosis: case report
Reactions Weekly, Vol. 1, Iss. 1290, 2010-01 ,pp. :